Trial Profile
Efficacy and safety of intravitreal bevacizumab in subjects with choroidal neovascularization secondary to pathological myopia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Nov 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Choroidal neovascularisation; Myopia
- Focus Therapeutic Use
- 14 Nov 2016 New trial record